Surgical Science Sweden AB (SUS) - Net Assets

Latest as of December 2025: Skr4.27 Billion SEK ≈ $459.85 Million USD

Based on the latest financial reports, Surgical Science Sweden AB (SUS) has net assets worth Skr4.27 Billion SEK (≈ $459.85 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr4.69 Billion ≈ $504.87 Million USD) and total liabilities (Skr418.31 Million ≈ $45.02 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SUS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr4.27 Billion
% of Total Assets	91.08%
Annual Growth Rate	53.74%
5-Year Change	19.19%
10-Year Change	18976.13%
Growth Volatility	236.02

Surgical Science Sweden AB - Net Assets Trend (2014–2025)

This chart illustrates how Surgical Science Sweden AB's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Surgical Science Sweden AB to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Surgical Science Sweden AB (2014–2025)

The table below shows the annual net assets of Surgical Science Sweden AB from 2014 to 2025. For live valuation and market cap data, see how much is Surgical Science Sweden AB worth.

Year	Net Assets	Change
2025-12-31	Skr4.27 Billion ≈ $459.85 Million	-11.51%
2024-12-31	Skr4.83 Billion ≈ $519.64 Million	+11.13%
2023-12-31	Skr4.35 Billion ≈ $467.61 Million	+2.57%
2022-12-31	Skr4.24 Billion ≈ $455.91 Million	+18.17%
2021-12-31	Skr3.59 Billion ≈ $385.81 Million	+739.50%
2020-12-31	Skr427.05 Million ≈ $45.96 Million	+6.32%
2019-12-31	Skr401.68 Million ≈ $43.23 Million	+406.00%
2018-12-31	Skr79.38 Million ≈ $8.54 Million	-7.18%
2017-12-31	Skr85.52 Million ≈ $9.20 Million	+281.79%
2016-12-31	Skr22.40 Million ≈ $2.41 Million	+14.29%
2015-12-31	Skr19.60 Million ≈ $2.11 Million	-47.96%
2014-12-31	Skr37.66 Million ≈ $4.05 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Surgical Science Sweden AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 72927385600.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	Skr706.23 Million	16.53%
Common Stock	Skr2.55 Million	0.06%
Other Components	Skr3.56 Billion	83.41%
Total Equity	Skr4.27 Billion	100.00%

Surgical Science Sweden AB Competitors by Market Cap

The table below lists competitors of Surgical Science Sweden AB ranked by their market capitalization.

Company	Market Cap
Siljansvik AB (publ) ST:SIVI	$171.36 Million
Forth Smart Service Public Company Limited BK:FSMART	$171.37 Million
Nice Information & Telecommunication Inc KQ:036800	$171.39 Million
QINGCI GAMES INC. -00001 F:Z56	$171.45 Million
Atlan Holdings Bhd KLSE:7048	$171.31 Million
JTC Inc KQ:950170	$171.31 Million
Securitag Assembly Group Co Ltd TWO:6417	$171.14 Million
Enad Global 7 AB ST:EG7	$171.06 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Surgical Science Sweden AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 4,828,639,000 to 4,273,054,000, a change of -555,585,000 (-11.5%).
Net income of 66,818,000 contributed positively to equity growth.
Other comprehensive income decreased equity by 788,557,000.
Other factors increased equity by 166,154,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr66.82 Million	+1.56%
Other Comprehensive Income	Skr-788.56 Million	-18.45%
Other Changes	Skr166.15 Million	+3.89%
Total Change	Skr-	-11.51%

Book Value vs Market Value Analysis

This analysis compares Surgical Science Sweden AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.37x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 23.81x to 0.37x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	Skr1.31	Skr31.20	x
2015-12-31	Skr0.81	Skr31.20	x
2016-12-31	Skr1.56	Skr31.20	x
2017-12-31	Skr4.36	Skr31.20	x
2018-12-31	Skr3.22	Skr31.20	x
2019-12-31	Skr13.83	Skr31.20	x
2020-12-31	Skr12.42	Skr31.20	x
2021-12-31	Skr84.02	Skr31.20	x
2022-12-31	Skr83.21	Skr31.20	x
2023-12-31	Skr85.30	Skr31.20	x
2024-12-31	Skr94.63	Skr31.20	x
2025-12-31	Skr83.74	Skr31.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Surgical Science Sweden AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 1.56%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 6.73%
• Asset Turnover: 0.21x
• Equity Multiplier: 1.10x
Recent ROE (1.56%) is below the historical average (1.81%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-16.18%	-7.39%	0.83x	2.63x	Skr-4.91 Million
2015	8.16%	3.47%	0.84x	2.79x	Skr-360.00K
2016	14.73%	6.37%	0.81x	2.84x	Skr1.06 Million
2017	-2.64%	-3.89%	0.59x	1.16x	Skr-10.81 Million
2018	-5.69%	-6.88%	0.66x	1.26x	Skr-12.46 Million
2019	3.14%	12.41%	0.22x	1.14x	Skr-27.57 Million
2020	3.65%	14.89%	0.22x	1.11x	Skr-27.10 Million
2021	2.41%	23.52%	0.09x	1.11x	Skr-272.26 Million
2022	4.44%	23.42%	0.17x	1.10x	Skr-235.67 Million
2023	5.38%	26.50%	0.19x	1.08x	Skr-200.55 Million
2024	2.73%	14.89%	0.16x	1.13x	Skr-351.22 Million
2025	1.56%	6.73%	0.21x	1.10x	Skr-360.49 Million

Industry Comparison

This section compares Surgical Science Sweden AB's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

Industry: Health Information Services
Average net assets among peers: $184,000,219
Average return on equity (ROE) among peers: 10.43%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Surgical Science Sweden AB (SUS)	Skr4.27 Billion	-16.18%	0.10x	$171.33 Million
Aino Health AB (AINO)	$1.98 Million	73.96%	3.57x	$2.69 Million
Carasent ASA (CARA)	$70.28 Million	-60.41%	1.01x	$166.91 Million
Kontigo Care AB (KONT)	$15.40 Million	-8.34%	0.59x	$5.16 Million
Medhelp Care AB (MEDHLP)	$8.68 Million	33.82%	4.47x	$22.60 Million
Physitrack PLC (PTRK)	$22.37 Million	0.41%	0.85x	$13.37 Million
RaySearch Laboratories AB (publ) (RAY-B)	$985.30 Million	23.12%	1.02x	$697.38 Million

About Surgical Science Sweden AB

ST:SUS Sweden Health Information Services

Market Cap

$171.33 Million

Skr1.59 Billion SEK

Market Cap Rank

#17270 Global

#289 in Sweden

Share Price

Skr31.20

Change (1 day)

-0.06%

52-Week Range

Skr23.92 - Skr158.30

All Time High

Skr324.75